Related Experiment Video
Updated: Apr 27, 2026
05:33
Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture
Published on: August 4, 2023
2.5K
Resistant cyclic vomiting syndrome successfully responding to chlorpromazine
Hasan H Ozdemir1, Serpil Bulut2, M Said Berilgen3
1Dicle University Neurology Department, Diyarbakır, Turkey.
Acta Medica (Hradec Kralove)
|July 10, 2014
Summary
Cyclic vomiting syndrome (CVS) is a challenging condition. This case study shows chlorpromazine effectively treated a young patient unresponsive to other therapies.
Area of Science:
- Gastroenterology
- Neurology
- Pharmacology
Background:
- Cyclic vomiting syndrome (CVS) presents as recurrent, stereotypical episodes of nausea and vomiting.
- Episodes can last for hours or days, with patients typically well between episodes.
- Standard treatments include antiemetics, antimigraine, and sedative medications.
Observation:
- A young patient experienced severe CVS symptoms.
- This patient was refractory to multiple conventional treatment agents.
- Standard therapies for CVS provided no relief.
Findings:
- The patient was successfully treated with chlorpromazine.
- Chlorpromazine demonstrated efficacy in a difficult-to-treat CVS case.
- This highlights a potential therapeutic option for refractory CVS.
Implications:
- Chlorpromazine may be a valuable option for managing refractory cyclic vomiting syndrome.
- Further research into chlorpromazine's role in CVS treatment is warranted.
- This case expands treatment possibilities for patients with severe, intractable CVS.
More Related Videos
Related Concept Videos
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.1K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.1K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
919
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
919
01:22Pathophysiology of Vomiting
4.5K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
4.5K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
816
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
816
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
1.4K
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.4K